Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$51.76 - $64.15 $3.06 Million - $3.79 Million
-59,073 Reduced 6.48%
852,438 $46.7 Million
Q1 2024

May 14, 2024

SELL
$48.6 - $57.12 $925,587 - $1.09 Million
-19,045 Reduced 2.05%
911,511 $51 Million
Q4 2023

Feb 13, 2024

BUY
$43.45 - $53.66 $2.21 Million - $2.73 Million
50,816 Added 5.78%
930,556 $48.1 Million
Q3 2023

Nov 09, 2023

BUY
$50.12 - $58.87 $10.5 Million - $12.3 Million
208,755 Added 31.11%
879,740 $46.5 Million
Q2 2023

Aug 11, 2023

SELL
$42.28 - $51.43 $4.25 Million - $5.17 Million
-100,557 Reduced 13.03%
670,985 $34.5 Million
Q1 2023

May 11, 2023

BUY
$40.84 - $58.14 $5.96 Million - $8.48 Million
145,888 Added 23.32%
771,542 $33.6 Million
Q4 2022

Feb 10, 2023

SELL
$43.88 - $56.16 $285,351 - $365,208
-6,503 Reduced 1.03%
625,654 $34.7 Million
Q3 2022

Nov 14, 2022

BUY
$48.37 - $66.5 $1.47 Million - $2.03 Million
30,478 Added 5.07%
632,157 $32.1 Million
Q2 2022

Aug 05, 2022

BUY
$57.25 - $86.63 $29.5 Million - $44.7 Million
515,914 Added 601.54%
601,679 $37.6 Million
Q1 2022

May 13, 2022

BUY
$71.02 - $86.99 $6.09 Million - $7.46 Million
85,765 New
85,765 $7.02 Million
Q2 2019

Aug 14, 2019

SELL
$66.45 - $97.36 $5.37 Million - $7.86 Million
-80,741 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$86.15 - $100.49 $2.04 Million - $2.37 Million
23,624 Added 41.36%
80,741 $7.85 Million
Q4 2018

Feb 14, 2019

BUY
$84.14 - $125.42 $4.8 Million - $7.15 Million
57,020 Added 58783.51%
57,117 $5.23 Million
Q3 2018

Nov 13, 2018

SELL
$101.02 - $130.95 $1,515 - $1,964
-15 Reduced 13.39%
97 $12,000
Q2 2018

Aug 14, 2018

SELL
$81.75 - $105.37 $817 - $1,053
-10 Reduced 8.2%
112 $11,000
Q4 2017

Feb 14, 2018

SELL
$71.8 - $88.21 $718 - $882
-10 Reduced 7.58%
122 $10,000
Q3 2017

Nov 14, 2017

BUY
$60.32 - $70.06 $7,962 - $9,247
132
132 $9,000

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.